SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-073125
Filing Date
2018-12-14
Accepted
2018-12-14 17:03:56
Documents
8
Period of Report
2018-12-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-41317_58k.htm 8-K 30989
2 EX-1.1 a18-41317_5ex1d1.htm EX-1.1 267594
3 EX-5.1 a18-41317_5ex5d1.htm EX-5.1 28905
4 EX-99.1 a18-41317_5ex99d1.htm EX-99.1 11848
5 EX-99.2 a18-41317_5ex99d2.htm EX-99.2 12335
6 GRAPHIC g413175kii001.jpg GRAPHIC 2537
7 GRAPHIC g413175mmi001.jpg GRAPHIC 3909
8 GRAPHIC g413175moi001.jpg GRAPHIC 3991
  Complete submission text file 0001104659-18-073125.txt   367656
Mailing Address 170 N RADNOR CHESTER RD SUITE 250 RADNOR PA 19087
Business Address 170 N RADNOR CHESTER RD SUITE 250 RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS INC (Filer) CIK: 0001267813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36576 | Film No.: 181236280
SIC: 2834 Pharmaceutical Preparations